Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- FRE.F
- Price
- 36.20
- Stock movement down
- -1.81 (-4.76%)
- Company name
- Fresenius SE & Co. KGaA
- Exchange
- (F ,
- Currency
- EUR )
- Sector
- Healthcare >Medical Care Facilities
- Market cap
- 20.39B
- Ent value
- 41.86B
- Price/Sales
- 0.92
- Price/Book
- 1.05
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- 0.25%
- Trailing P/E
- -
- Forward P/E
- 10.48
- PEG
- -
- EPS growth
- -
- 1 year return
- 42.86%
- 3 year return
- 2.99%
- 5 year return
- -1.50%
- 10 year return
- -3.72%
Last updated: 2025-04-12
DIVIDENDS
FRE.F does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | 6.42 |
| Price to FCF | 8.59 |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 0.92 |
| Price to Book | 1.05 |
| EV to Sales | 1.88 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 563.24M |
| EPS (TTM) | -0.68 |
| FCF per share (TTM) | 4.21 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 22.21B |
| Gross profit (TTM) | 5.29B |
| Operating income (TTM) | 1.40B |
| Net income (TTM) | -383.00M |
| EPS (TTM) | -0.68 |
| EPS (1y forward) | 3.45 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 23.82% |
| Operating margin (TTM) | 6.31% |
| Profit margin (TTM) | -1.72% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 1.49B |
| Net receivables | 3.82B |
| Total current assets | 11.23B |
| Goodwill | 14.75B |
| Intangible assets | 2.35B |
| Property, plant and equipment | 9.70B |
| Total assets | 42.37B |
| Accounts payable | 1.22B |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 8.28B |
| Total liabilities | 22.96B |
| Shareholder's equity | 19.40B |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 3.18B |
| Capital expenditures (TTM) | 803.00M |
| Free cash flow (TTM) | 2.37B |
| Dividends paid (TTM) | 6.00M |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -1.97% |
| Return on Assets | -0.90% |
| Return on Invested Capital | -1.30% |
| Cash Return on Invested Capital | 8.03% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 37.55 |
| Daily high | 37.55 |
| Daily low | 36.20 |
| Daily Volume | 2K |
| All-time high | 175.56 |
| 1y analyst estimate | 40.86 |
| Beta | 1.04 |
| EPS (TTM) | -0.68 |
| Dividend per share | - |
| Ex-div date | 26 May 2025 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| FRE.F | S&P500 | |
| Current price drop from All-time high | -79.38% | -14.41% |
| Highest price drop | -98.72% | -56.47% |
| Date of highest drop | 10 Oct 2002 | 9 Mar 2009 |
| Avg drop from high | -78.48% | -11.07% |
| Avg time to new high | 77 days | 12 days |
| Max time to new high | 7438 days | 1805 days |
COMPANY DETAILS
Marketcap
20.39B
Marketcap category
Large-cap
Description
Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.
Employees
177091
Website
Investor relations
-
SEC filings
CEO
Country
Germany
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
April 11, 2025
Delcath Systems (DCTH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near t...
April 10, 2025
Pacira Biosciences, Edgewise, Sarepta Therapeutics, Amgen and Bristol Myers Squibb are included in this Analyst Blog.
April 10, 2025
PCRX and EWTX are in the spotlight this week following important regulatory and pipeline news.
April 9, 2025
Pacira BioSciences stock rises as it settles Exparel patent litigation with several generic players protecting the drug's exclusivity in the United States at least until 2030.
April 8, 2025
(Updates with stock price movement in the first paragraph and headline.) Pacira Biosciences (PCRX
April 8, 2025
Pacira Biosciences (PCRX) said Monday it settled the litigations with Fresenius Kabi USA, Jiangsu He
April 7, 2025
Nevro (NVRO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
April 3, 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
April 1, 2025
Fresenius SE KGaA ( ETR:FRE ) Full Year 2024 Results Key Financial Results Revenue: €21.8b (up 3.6% from FY 2023). Net...
March 29, 2025
Next page